SCHEMBL7835709

SCHEMBL7835709

FC(F)(F)COc1ccccc1N1CCN(CCCBr)CC1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 10/20 0.60
ADRA1B P35368 10/20 0.60
ADRA1D P25100 9/20 0.60
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
DRD2 P14416 2/20 0.54
DRD3 P35462 2/20 0.54
HTR1A P08908 1/20 0.49
LMNA P02545 2/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 1/20 0.47
NLRP1 Q9C000 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771682 0.87 ADRA1A (0.60) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL9028727 0.87 ADRA1A (0.60) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL6770339 0.81 DRD2 (0.70) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL24712880 0.81 DRD2 (0.59) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL5157991 0.80 ADRA1A (0.62) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL5416601 0.80 ADRA1A (0.69) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL7821310 0.80 DRD2 (0.76) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
Hydrochloric Acid SCHEMBL5430150 0.79 ADRA1A (0.68) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL5424177 0.79 ADRA1A (0.62) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
Hydrochloric Acid SCHEMBL5428298 0.79 ADRA1A (0.61) ADRA1AADRA1BADRA1DCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed